Cardiol Therapeutics Bolsa (NASDAQ: CRDL)

Últimas noticias sobre Cardiol Therapeutics (NASDAQ:CRDL) Bolsa

Cardiol Therapeutics

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

Sadot Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) ("Sadot Group", "Sadot", or the "Company"), an emerging player in the global agri-food supply chain, is proud to announce that its newly established subsidiary, Sadot Korea, has successfully executed its first international commodity trades. These initial transactions involved sourcing food products from Australia and Indonesia, with final delivery to key markets in Kenya and other countries.
The launch of Sadot Korea, announced on March 26, 2025, represents a major milestone in the Company's strategy to expand its footprint in Northeast Asia. Leveraging South Korea's robust logistics and trade infrastructure, Sadot aims to establish the country as a hub for global agri-trade activity.

News

SDOT

Sadot Group Inc Announces First Commodity Trades Through New South Korea Subsidiary

Stifel analyst Rick Wise maintains Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Buy and raises the price target from $135 to $145.

Price Target

Analyst Ratings

Stifel Maintains Buy on Abbott Laboratories, Raises Price Target to $145

TYSONS, Va. and INDIANAPOLIS, April 17, 2025 (GLOBE NEWSWIRE) -- The Indiana Fever and WTHR, the TEGNA owned NBC affiliate in Indianapolis, today announced a multi-year extension of their landmark distribution agreement to deliver more exciting basketball action to central Indiana fans than ever before.
WTHR and WALV, TEGNA's MeTV affiliate, will air 18 games locally, giving fans across central Indiana unprecedented access to watch the Fever in action as they fight for a return to the WNBA playoffs. Last season, WTHR's coverage elevated Indiana Fever viewership to new heights as the team's local broadcast home, broadening the fan base beyond hardcore sports enthusiasts. Fever games on WTHR were watched in nearly two-thirds more homes than nationally televised matchups, boasting a 63% household ratings increase over national network games.

TGNA

Indiana Fever And WTHR Announce Multi-year Extension Of Distribution Agreement To Deliver More Exciting Basketball Action To Central Indiana Fans

Acme United (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ACU#AMEX">ACU</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.59 by 30.51 percent. This is a 5.13 percent increase over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $45.96 million which missed the analyst consensus estimate of $46.98 million by 2.17 percent. This is a 2.23 percent increase over sales of $44.96 million the same period last year.

Earnings

Earnings Misses

Acme United Q1 EPS $0.41 Misses $0.59 Estimate, Sales $45.96M Miss $46.98M Estimate

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.tetratech.com%2F&amp;esheet=54239498&amp;newsitemid=20250416943687&amp;lan=en-US&amp;anchor=Tetra+Tech%2C+Inc.&amp;index=1&amp;md5=89c41e10623e059dc387961391a88704">Tetra Tech, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today that the City of Bartlesville, Oklahoma, has awarded Tetra Tech a contract to provide engineering design and technical services for the first indirect potable reuse (IPR) project to be permitted within the State of Oklahoma.
Building upon Tetra Tech's initial IPR pilot study, Tetra Tech engineers and technical specialists will now design innovative IPR solutions to expand the Chickasaw Wastewater Treatment Plant's capacity by 15 percent. Tetra Tech will use advanced treatment processes to treat up to 50 percent of daily wastewater flows which will be redirected several miles upstream into the Caney River to be recaptured, retreated, and distributed through the City's water system during times of extreme drought.
"Tetra Tech is pleased to partner with the City of Bartlesville on this innovative project, the first indirect potable reuse facility in Oklahoma," said Dan Batrack, Tetra Tech Chairman and CEO. "We will use our Leading with Science&#xAE; approach to deliver advanced water reuse solutions that help extend Bartlesville's water supply by up to 40 years and support the State of Oklahoma's forward-looking ‘Water for 2060' goals."
&nbsp;

Contracts

TTEK

Tetra Tech Announces The City Of Bartlesville, Oklahoma Has Awarded A Contract To Provide Engineering Design And Technical Services For First Indirect Potable Reuse Project To Be Permitted Within The State Of Oklahoma

WIIM

SLNH

Soluna Holdings shares are trading higher after the company announced it signed a term sheet to power the Ellen data center project.

SOUTHLAKE, Texas and DUBAI, United Arab Emirates, April 17, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4407047-1&amp;h=491652646&amp;u=https%3A%2F%2Fwww.sabrehospitality.com%2F%3Futm_source%3Dsabre%26utm_medium%3Dpr%26utm_campaign%3Dmktg_md_WebContent%26utm_content%3Dsh_website_pr&amp;a=Sabre+Hospitality">Sabre Hospitality</a>, a division of&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4407047-1&amp;h=3087257568&amp;u=http%3A%2F%2Fsabre.com%2F&amp;a=Sabre+Corporation">Sabre Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>) a leading global travel technology company, has announced a renewal agreement with Kerzner International, optimizing its distribution with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4407047-1&amp;h=1679536891&amp;u=https%3A%2F%2Fwww.sabrehospitality.com%2Fresources%2Farticle%2Fpersonalized-experiences-how-retailing-software-meets-hospitalitys-growing-demand%2F&amp;a=retailing+capabilities">retailing capabilities</a> through Sabre's SynXis platform. By leveraging the SynXis Booking Engine, Kerzner will be offering ancillaries alongside room reservations. Additionally, Kerzner has renewed its agreement to distribute hotel content through Sabre Hospitality's Global Distribution System network.&nbsp;

SABR

Sabre's Division Sabre Hospitality Renews Agreement With Kerzner International To Optimize Distribution With Retailing Capabilities Through Sabre's SynXis Platform

Snap-On Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) reported disappointing expected <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44859295/snap-on-announces-first-quarter-2025-results" rel="noreferrer noopener">first-quarter 2025 results</a>, falling short of both revenue and earnings consensus estimates.
Here&#8217;s a breakdown of the report:
<ul>
<li>Quarterly net sales reached $1.141 billion, reflecting a 3.5% year-over-year increase and below the consensus estimate of $1.20 billion.</li>
<li>Sales were impacted by a 2.3% organic decline and a $13.9 million negative effect from unfavorable foreign currency translation.&nbsp;&nbsp;&nbsp;</li>
<li>The gross margin expanded by 23 bps to 50.7%, and gross profit fell 3.1% year over year to $578.5 million.</li>
<li>Financial services revenue rose to $102.1 million, with operating earnings at $70.3 million, up from $99.6 million and $68.3 million, respectively, in 2024.</li>
<li>Consolidated operating earnings were $313.4 million, or 25.2% of revenues, compared to $339.2 million, or 26.5% of revenues, in 2024, which included an $11.3 million legal payments benefit.</li>
<li>EPS for the quarter was $4.51, down from $4.91 YoY, below the consensus of $4.84.</li>
<li>Operating cash flow for the quarter totaled $298.5 million, compared to $348.7 million a year ago, with $1.434 billion in cash and equivalents at the quarter&#8217;s end.</li>
</ul>
Sales by segments:
<ul>
<li>Commercial &amp; Industrial $343.9 million (-2.9% YoY)</li>
<li>Snap-on Tools $462.9 million (-6.8% YoY)</li>
<li>Repair Systems &amp; Information $475.9 million (+3.7% YoY).</li>
</ul>
&#8220;As we move forward, we believe strongly in our long-established strategy to largely produce in the countries and regions where we sell and in our broad manufacturing capacity in the U.S., fortified by extensive facilities, enabled by deep process know-how, and fueled by experienced associates… all structural advantages that position us well to navigate today&#8217;s world,&#8221; said Snap-on CEO Nick Pinchuk.
&#8220;These are times of expanding turbulence. We are, however, confident, holding great belief in the criticality of our markets across essential repair, the considerable capabilities of our battle-tested team, and the power of our continuing investments in product, brand, and people.&#8221;
Outlook 2025: Snap-on expects to continue demonstrating resilience, focusing on growth in automotive repair and expanding into adjacent markets and critical industries.
The company plans to spend approximately $100 million on capital expenditures in 2025, with $22.9 million already spent in the first quarter.
Snap-on anticipates an effective income tax rate for 2025 in the range of 22% to 23%.
Price Action: Snap-on shares closed 1.50% lower at $332 on Wednesday.
Photo: Shutterstock

Guidance

Snap-On's Q1 Results Underwhelm, CEO Stresses Resilience And Strategic Advantage Moving Forward

CYCU

Cycurion shares are trading higher after the company reported a year-over-year increase in FY24 EPS results.

Management

Lockheed Martin Appoints Evan Scott As Senior Vice President And CFO; Effective Immediately

Fidelity National Information Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) on Thursday unveiled two strategic moves—acquiring Global Payments&#8217; Issuer Solutions unit and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44859301/fis-announces-sale-of-worldpay-stake-and-strategic-acquisition-of-global-payments-issuer-solutions" rel="noreferrer noopener">selling its remaining stake in Worldpay.</a>
What Happened: The Jacksonville, Florida-based firm agreed to purchase Global Payments&#8217; Issuer Solutions arm in a transaction valued at $13.5 billion. The deal includes $1.5 billion in projected tax-related benefits, resulting in a net outlay of $12 billion.
Simultaneously, Fidelity National will offload its 45% stake in Worldpay to Global Payments for $6.6 billion in pre-tax proceeds.
Fidelity National CEO Stephanie Ferris described the acquisition as a &#8220;high-margin&#8221; growth opportunity.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44857887/taiwan-semiconductor-q1-surges-41-in-sales-boosted-by-ai-chip-demand-expanded-margins" rel="noreferrer noopener">Taiwan Semiconductor CFO Anticipates Tariffs Impact But Has Not Seen Change In Customer Behavior Yet, Issues Strong Q2 Outlook</a>
Why It Matters: The Issuer Solutions platform processes over 40 billion transactions annually, serving clients across more than 75 countries.
It is expected to bolster Fidelity National&#8217;s existing suite of services in debit and banking infrastructure. It could also broaden access to a $28 billion global issuer market—including $15 billion in the U.S. alone.
&#8220;Issuer Solutions&#8217; globally scaled credit processing capabilities are highly complementary to FIS&#8217; established debit processing capabilities, strengthening our broader banking and capital markets offering,&#8221; Ferris said.
Separately, GTCR—which acquired a 55% majority stake in Worldpay from Fidelity National in 2023—will now sell the payments<a href="https://www.benzinga.com/pressreleases/25/04/n44859362/gtcr-announces-sale-of-worldpay-to-global-payments-for-24-25-billion-in-conjunction-with-transform" target="_blank" rel="noreferrer noopener"> firm to Global Payments for $24.25 billion.</a> The private equity firm will receive 59% cash and 41% stock consideration as part of the Worldpay transaction.
Upon closing, GTCR will own shares representing 15% of Global Payments&#8217; outstanding shares.
CEO Charles Drucker will continue to lead the Worldpay team through the transition and future integration.
What&#8217;s Next: Fidelity National intends to finance the acquisition with $8 billion in new debt alongside proceeds from the Worldpay sale.
The purchase price for Issuer Solutions reflects a valuation of approximately 9 times expected 2025 EBITDA. The Worldpay sale to Global Payments stands at about 10.5 times expected 2025 EBITDA.
These two interlinked transactions are expected to close in the first half of 2026.
Following completion, Fidelity National plans to momentarily pause share repurchases and M&amp;A activity to prioritize reducing its debt.
1Q 2025&nbsp;Update
Fidelity National will release official earnings release scheduled for May 6. The company said it reported total preliminary revenue of about $2.5 billion versus the estimate of $2.57 billion. The <a href="https://www.investor.fisglobal.com/news-releases/news-release-details/fis-reports-full-year-2024-results-and-2025-outlook-confirms#:~:text=Full%2DYear%202024%20Financial%20Results&amp;text=approximately%20%2410.1%20billion.-,GAAP%20net%20earnings%20attributable%20to%20common%20stockholders%20from%20continuing%20operations,by%204%25%20recurring%20revenue%20growth." target="_blank" rel="noreferrer noopener">prior view</a> was $2.485 billion- $2.51 billion. This reflected adjusted and recurring revenue growth of around 4%.
Adjusted EBITDA came in at roughly $958 million, while adjusted earnings per share stood at approximately $1.21 versus the analyst consensus estimate of $1.28 (prior view: $1.17&nbsp;&#8211;&nbsp;$1.22).
Price Action: FIS shares are trading lower by 0.93% to $68.00 premarket at last check Thursday. GPN shares are trading lower by 2.29% to $82.19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44849610/bitcoin-miners-buckle-under-april-price-pressure-but-jp-morgan-analyst-says-mara-cleanspark-held-strong" target="_blank" rel="noreferrer noopener">Bitcoin Miners Buckle Under April Price Pressure, But JP Morgan Analyst Says MARA, CleanSpark Held Strong</a></li>
</ul>
Image: Shutterstock

Equities

Markets

Movers

General

Fidelity National Unloads Worldpay Stake To Global Payments For $6.6 Billion, Scoops Up Issuer Unit For $12 Billion

Social Media

FUBO

Fubo Retains Exclusive Rights To Premier League In Canada Beginning With 2025-2026 Season

CMND

Clearmind Medicine shares are trading higher after the company announced the US Patent Office has issued a notice of allowance relating to its MEAI treatment for binge behavior.

In the last three months, 5 analysts have published ratings on Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $24.7, a high estimate of $27.00, and a low estimate of $20.00. Highlighting a 7.66% decrease, the current average has fallen from the previous average price target of $26.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1744894886_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Penguin Solutions. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $27.00&#x7C;$27.00 &#x7C; 
&#x7C;Michael Ng &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $22.50&#x7C;$26.00 &#x7C; 
&#x7C;Quinn Bolton &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $27.00&#x7C;$27.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $27.00&#x7C;$27.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Announces &#x7C;Neutral &#x7C; $20.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Penguin Solutions. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Penguin Solutions compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Penguin Solutions's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Penguin Solutions's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PENG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Penguin Solutions analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Penguin Solutions</h2>
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC &amp; AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC &amp; AI Systems includes OCP Servers &amp; Storage and etc.
<h3>Penguin Solutions: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Penguin Solutions's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 28.33% as of 28 February, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 1.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Penguin Solutions's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.0%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Penguin Solutions's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.29% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Penguin Solutions's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.19, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Penguin Solutions, Inc. - Ordinary Shares

PENG

Beyond The Numbers: 5 Analysts Discuss Penguin Solutions Stock

19 analysts have shared their evaluations of Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">2</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $71.46, a high estimate of $105.00, and a low estimate of $44.00. Observing a downward trend, the current average is 13.19% lower than the prior average price target of $82.32. 
<img src="https://www.benzinga.com/files/images/story/2025/1744894876_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Enphase Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $47.00&#x7C;$65.00 &#x7C; 
&#x7C;Vikram Bagri &#x7C;Citigroup &#x7C;Announces &#x7C;Sell &#x7C; $47.00&#x7C;- &#x7C; 
&#x7C;Christine Cho &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $58.00&#x7C;$86.00 &#x7C; 
&#x7C;Biju Perincheril &#x7C;Susquehanna &#x7C;Lowers &#x7C;Neutral &#x7C; $59.00&#x7C;$76.00 &#x7C; 
&#x7C;Jeffrey Osborne &#x7C;TD Cowen &#x7C;Lowers &#x7C;Buy &#x7C; $78.00&#x7C;$94.00 &#x7C; 
&#x7C;Sean Milligan &#x7C;Jefferies &#x7C;Lowers &#x7C;Underperform &#x7C; $44.00&#x7C;$54.00 &#x7C; 
&#x7C;Praneeth Satish &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $75.00&#x7C;$77.00 &#x7C; 
&#x7C;Praneeth Satish &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $77.00&#x7C;$83.00 &#x7C; 
&#x7C;Christine Cho &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $86.00&#x7C;$91.00 &#x7C; 
&#x7C;Biju Perincheril &#x7C;Susquehanna &#x7C;Lowers &#x7C;Neutral &#x7C; $76.00&#x7C;$79.00 &#x7C; 
&#x7C;Kashy Harrison &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $65.00&#x7C;$70.00 &#x7C; 
&#x7C;Colin Rusch &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $103.00&#x7C;$101.00 &#x7C; 
&#x7C;Eric Stine &#x7C;Craig-Hallum &#x7C;Lowers &#x7C;Buy &#x7C; $101.00&#x7C;$123.00 &#x7C; 
&#x7C;Ameet Thakkar &#x7C;BMO Capital &#x7C;Lowers &#x7C;Market Perform &#x7C; $66.00&#x7C;$69.00 &#x7C; 
&#x7C;Andrew Percoco &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $67.00&#x7C;$68.00 &#x7C; 
&#x7C;Gordon Johnson &#x7C;GLJ Research &#x7C;Maintains &#x7C;Sell &#x7C; $50.69&#x7C;$50.69 &#x7C; 
&#x7C;Joseph Osha &#x7C;Guggenheim &#x7C;Maintains &#x7C;Neutral &#x7C; $62.00&#x7C;$62.00 &#x7C; 
&#x7C;Mark Strouse &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $91.00&#x7C;$112.00 &#x7C; 
&#x7C;Brian Lee &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $105.00&#x7C;$121.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Enphase Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Enphase Energy compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Enphase Energy's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Enphase Energy's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ENPH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Enphase Energy analyst ratings.</a>
<h2>Delving into Enphase Energy's Background</h2>
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
<h3>Enphase Energy's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Enphase Energy's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 26.49%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 16.24%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.05%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Enphase Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.91% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 1.57, Enphase Energy faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ENPH

A Glimpse Into The Expert Outlook On Enphase Energy Through 19 Analysts

4 analysts have shared their evaluations of CDW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDW#NASDAQ">CDW</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CDW, revealing an average target of $189.75, a high estimate of $223.00, and a low estimate of $160.00. Observing a downward trend, the current average is 9.21% lower than the prior average price target of $209.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744894868_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of CDW by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $175.00&#x7C;$222.00 &#x7C; 
&#x7C;Asiya Merchant &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $160.00&#x7C;$220.00 &#x7C; 
&#x7C;Erik Woodring &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $201.00&#x7C;$193.00 &#x7C; 
&#x7C;George Wang &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $223.00&#x7C;$201.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CDW. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of CDW compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of CDW's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into CDW's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CDW/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CDW analyst ratings.</a>
<h2>Discovering CDW: A Closer Look</h2>
CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has five operating segments namely, Corporate, Small Business, Public, CDW UK, and CDW Canada. The Corporate segment generates the majority of its revenue and serves USA private sector business customers.
<h3>Understanding the Numbers: CDW's Finances</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: CDW's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 3.34%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.09%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CDW's ROE excels beyond industry benchmarks, reaching 11.24%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): CDW's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.82% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 2.55, CDW faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss CDW Stock

In the latest quarter, 6 analysts provided ratings for Redwood Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RWT#NYSE">RWT</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Redwood Trust and provided 12-month price targets. The average target is $7.17, accompanied by a high estimate of $8.00 and a low estimate of $5.50. Experiencing a 7.48% decline, the current average is now lower than the previous average price target of $7.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1744894860_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Redwood Trust among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Jason Weaver &#x7C;Jones Trading &#x7C;Lowers &#x7C;Buy &#x7C; $7.00&#x7C;$8.00 &#x7C; 
&#x7C;Richard Shane &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $5.50&#x7C;$6.50 &#x7C; 
&#x7C;Jason Weaver &#x7C;Jones Trading &#x7C;Maintains &#x7C;Buy &#x7C; $8.00&#x7C;$8.00 &#x7C; 
&#x7C;Trevor Cranston &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $8.00&#x7C;$8.00 &#x7C; 
&#x7C;Chris Muller &#x7C;JMP Securities &#x7C;Lowers &#x7C;Market Outperform&#x7C; $8.00&#x7C;$9.00 &#x7C; 
&#x7C;Richard Shane &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $6.50&#x7C;$7.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Redwood Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Redwood Trust compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Redwood Trust's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Redwood Trust's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/RWT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Redwood Trust analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Redwood Trust's Background</h2>
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
<h3>Breaking Down Redwood Trust's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: Redwood Trust's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -37.96%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Redwood Trust's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -35.97%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Redwood Trust's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -1.12%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Redwood Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.07%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Redwood Trust's debt-to-equity ratio surpasses industry norms, standing at 14.63. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Redwood Trust: Insights From 6 Analyst Reviews

Vertex Pharmaceuticals's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NYSE">VRTX</a>) short percent of float has fallen 22.32% since its last report. The company recently reported that it has 4.46 million shares sold short, which is 1.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.26 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Vertex Pharmaceuticals Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744894853_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Vertex Pharmaceuticals has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Vertex Pharmaceuticals's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

VRTX

Peering Into Vertex Pharmaceuticals's Recent Short Interest

In the last three months, 4 analysts have published ratings on Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>), offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Calix, revealing an average target of $44.25, a high estimate of $53.00, and a low estimate of $34.00. This current average reflects an increase of 2.31% from the previous average price target of $43.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1744894851_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive Calix is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $34.00&#x7C;$45.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $45.00&#x7C;$38.00 &#x7C; 
&#x7C;Ryan Koontz &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $53.00&#x7C;$45.00 &#x7C; 
&#x7C;Ryan Koontz &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $45.00&#x7C;$45.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Calix. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Calix compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Calix's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Calix's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CALX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Calix analyst ratings.</a>
<h2>Discovering Calix: A Closer Look</h2>
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East &amp; Africa, Europe, Asia Pacific and other markets.
<h3>Financial Milestones: Calix's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Calix's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -22.14%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Calix's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -8.7%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.3%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Calix's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.91%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CALX

Demystifying Calix: Insights From 4 Analyst Reviews

Yum China Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) short percent of float has fallen 18.09% since its last report. The company recently reported that it has 8.97 million shares sold short, which is 2.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.03 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Yum China Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744894848_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Yum China Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Yum China Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Yum China Holdings's peer group average for short interest as a percentage of float is 9.94%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

YUMC

How Is The Market Feeling About Yum China Holdings?

Press Releases

"Game-Changers to Watch CRDL, RMSG, WORX, PET and more…Innovative Companies inside"

Thanksgiving Week Oversold Stocks to Watch: CRDL, QBTS, PRSO, RGTI & More!

"Market Movers: CTOR, CTNT, PNPN.V, KITT, SHIM – More Stocks Inside to Watch"

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Comments

Cardiol Therapeutics

Noticias

Últimas noticias sobre Cardiol Therapeutics (NASDAQ:CRDL) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL